Moderna (NASDAQ: MRNA) reported Q1 EPS of ($2.52), $0.66 better than the analyst estimate of ($3.18). Revenue for the quarter came in at $108 million versus the consensus estimate of $115.3 million.

GUIDANCE:

Moderna sees FY2025 revenue of $1.5-2.5 billion, versus the consensus of $2.13 billion.

For earnings history and earnings-related data on Moderna (MRNA) click here.